| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 82P4S8Q3FB |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Programmed cell death 1 ligand 1 inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Small Cell Lung Carcinoma | 3 | D055752 | ClinicalTrials |
| Osteosarcoma | 3 | D012516 | ClinicalTrials |
| Melanoma | 1 | D008545 | ClinicalTrials |
| Urinary Bladder Neoplasms | 1 | D001749 | ClinicalTrials |
| Uterine Cervical Neoplasms | 1 | D002583 | ClinicalTrials |
| Biliary Tract Neoplasms | 1 | D001661 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4802221 |
| FDA SRS | 82P4S8Q3FB |
CONTENTS